Collaborations & key partners

Key partnerships

We are setting up a unique platform in immuno-oncology, which brings together robust analytical technologies and innovative assays for cancer immunotherapies testing. To gain access to the latest technologies, we have built a network of key technological partners:

Collaborations & key partners
Cisbio Assays

With its HTRF assay platform, Cisbio provides a full breath offering of immunoassays, reagents and custom solutions that enable researchers to accelerate their projects. HTRF  fluorescence-based assays cover a wide variety of targets and cellular readouts fwhich make the platform one of the gold standards for early drug discovery and screening.

Essen BioSciences

Essen BioScience

Word leader in the field of live-cell in vitro assays and instrumentation, Essen BioScience supports the in vitro services of Explicyte Immuno-Oncology.


Scientific collaborators

  • ANTOINE ITALIANO, MD, PHD ANTOINE ITALIANO, MD, PHD Medical oncologist, Inst. Bergonié Head of the Early Phase Trials and Sarcoma Units at the Bergonié Comprehensive Cancer Center in Bordeaux, France.
  • GILLES GUILLEMIN, PHD GILLES GUILLEMIN, PHD Professor, Macquarie University Professor of Neurosciences, expert in tryptophan metabolism, Faculty of MEdicine and Health Sciences, University of Macquarie, Australia.
  • PATRICK LEGEMBRE, PHD PATRICK LEGEMBRE, PHD Research Director, OSS lab, CLCC Eugène Marquis Research director in the Oncogenesis Stress Signaling lab at the Eugene Marquis Comprehensive Cancer Center in Rennes, France.
  • FRANCESCA FALLARINO, PHD FRANCESCA FALLARINO, PHD Immunologist, University of Perugia Francesca Fallarino, Associate Professor at University of Perugia, Department of Experimental Medicine, Perugia, Italy
  • DAVID GILOT, PHD DAVID GILOT, PHD Researcher, IGDR, Rennes 1 University Researcher, Institut de Génétique et Développement de Rennes, Rennes 1 University, France